KRYS logo

Krystal Biotech (KRYS) EBIT

Annual EBIT

$12.90 M
+$152.87 M+109.21%

December 31, 2023

Summary

Performance

1-Year Change

+109.21%

3-Year Change

+140.09%

5-Year Change

+208.23%

15-Year Change

+370.26%

KRYS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.16%
KRYS annual earnings before interest & taxes is higher than 84.16% of companies in Healthcare sector

High & Low

All-time High

$12.90 M
KRYS annual earnings before interest & taxes is currently at an all-time high

3-Year Low

-$139.97 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
KRYS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 26, 2025
KRYS next annual earnings announcement is scheduled for Feb 26, 2025

OtherKRYSprofitabilitymetrics:

Annual Revenue

$50.70 M
KRYS annual revenue is $50.70 million

Annual Net Income

$10.93 M
KRYS annual net profit is $10.93 million

Annual EBITDA

$17.90 M
KRYS annual EBITDA is $17.90 million

Annual EPS

$0.39
KRYS annual earnings per share is $0.39

Quarterly EBIT

$34.93 M
+$13.87 M+65.83%

September 30, 2024

Summary

Performance

3-Month Change

+65.83%

1-Year Change

+234.39%

3-Year Change

+164.04%

5-Year Change

+164.04%

KRYS Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.05%
KRYS quarterly earnings before interest & taxes is higher than 88.05% of companies in Healthcare sector

High & Low

All-time High

$113.26 M
KRYS quarterly earnings before interest & taxes is currently -69.16% below its historical high of $113.26 million

3-Year Low

-$54.55 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
KRYS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
KRYS next earnings announcement is scheduled for Feb 26, 2025

OtherKRYSprofitabilitymetrics:

Quarterly Revenue

$83.84 M
KRYS quarterly revenue is $83.84 million

Quarterly Net Income

$27.18 M
KRYS quarterly net profit is $27.18 million

Quarterly EBITDA

$36.46 M
KRYS quarterly EBITDA is $36.46 million

Quarterly EPS

$0.91
KRYS quarterly earnings per share is $0.91

TTM EBIT

$175.08 M
+$60.93 M+53.37%

September 30, 2024

Summary

Performance

3-Month Change

+53.37%

1-Year Change

+213.02%

3-Year Change

+225.08%

5-Year Change

+225.08%

KRYS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.42%
KRYS TTM earnings before interest & taxes is higher than 90.42% of companies in Healthcare sector

High & Low

All-time High

$175.08 M
KRYS TTM earnings before interest & taxes is currently at an all-time high

3-Year Low

-$160.37 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
KRYS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
KRYS next earnings announcement is scheduled for Feb 26, 2025

OtherKRYSprofitabilitymetrics:

TTM Revenue

$241.52 M
KRYS TTM revenue is $241.52 million

TTM Net Income

$52.37 M
KRYS TTM net profit is $52.37 million

TTM EBITDA

$181.09 M
KRYS TTM EBITDA is $181.09 million

TTM EPS

$1.78
KRYS TTM earnings per share is $1.78

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

$12.90 M
KRYS annual earnings before interest & taxes is $12.90 million

Annual Revenue

$50.70 M
KRYS annual revenue is $50.70 million

Annual Cost Of Goods Sold

$3.09 M
KRYS annual cost of goods sold is $3.09 million

Annual Operating Expenses

$144.83 M
KRYS annual total operating expenses is $144.83 million

KRYS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+109.2%+234.4%+213.0%
3 y3 years+140.1%+164.0%+225.1%
5 y5 years+208.2%+164.0%+225.1%

KRYS EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+109.2%-69.2%+164.0%at high+209.2%
5 y5-yearat high+109.2%-69.2%+164.0%at high+209.2%
alltimeall timeat high+109.2%-69.2%+164.0%at high+209.2%

Krystal Biotech EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
$34.93 M(+65.8%)
$175.08 M(+53.4%)
Jun 2024
-
$21.07 M(+262.2%)
$114.15 M(+107.4%)
Mar 2024
-
$5.82 M(-94.9%)
$55.04 M(+326.7%)
Dec 2023
$12.90 M(-109.2%)
$113.26 M(-535.7%)
$12.90 M(-108.3%)
Sep 2023
-
-$25.99 M(-31.7%)
-$154.91 M(-3.4%)
Jun 2023
-
-$38.05 M(+4.7%)
-$160.37 M(+6.2%)
Mar 2023
-
-$36.32 M(-33.4%)
-$151.08 M(+7.9%)
Dec 2022
-$139.97 M(+105.6%)
-$54.55 M(+73.4%)
-$139.98 M(+30.5%)
Sep 2022
-
-$31.45 M(+9.4%)
-$107.23 M(+17.4%)
Jun 2022
-
-$28.75 M(+14.0%)
-$91.37 M(+15.7%)
Mar 2022
-
-$25.22 M(+15.7%)
-$78.98 M(+16.0%)
Dec 2021
-$68.08 M(+111.6%)
-$21.81 M(+39.9%)
-$68.08 M(+20.2%)
Sep 2021
-
-$15.59 M(-4.7%)
-$56.66 M(+11.8%)
Jun 2021
-
-$16.36 M(+14.3%)
-$50.68 M(+23.2%)
Mar 2021
-
-$14.32 M(+37.9%)
-$41.15 M(+27.9%)
Dec 2020
-$32.17 M
-$10.38 M(+8.0%)
-$32.17 M(+15.1%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$9.61 M(+40.6%)
-$27.94 M(+18.0%)
Jun 2020
-
-$6.83 M(+27.9%)
-$23.67 M(+4.1%)
Mar 2020
-
-$5.34 M(-13.2%)
-$22.73 M(+2.9%)
Dec 2019
-$22.08 M(+85.3%)
-$6.15 M(+15.2%)
-$22.08 M(+9.6%)
Sep 2019
-
-$5.34 M(-9.3%)
-$20.14 M(+13.3%)
Jun 2019
-
-$5.89 M(+25.5%)
-$17.77 M(+24.0%)
Mar 2019
-
-$4.69 M(+11.3%)
-$14.33 M(+20.3%)
Dec 2018
-$11.92 M(+149.7%)
-$4.22 M(+42.0%)
-$11.92 M(+29.6%)
Sep 2018
-
-$2.97 M(+21.4%)
-$9.20 M(+10.6%)
Jun 2018
-
-$2.45 M(+7.6%)
-$8.32 M(+26.3%)
Mar 2018
-
-$2.28 M(+52.0%)
-$6.58 M(+38.0%)
Dec 2017
-$4.77 M(+317.5%)
-$1.50 M(-28.4%)
-$4.77 M(+22.6%)
Sep 2017
-
-$2.09 M(+192.7%)
-$3.89 M(+83.5%)
Jun 2017
-
-$715.00 K(+53.8%)
-$2.12 M(+50.8%)
Mar 2017
-
-$465.00 K(-25.0%)
-$1.41 M(+49.4%)
Dec 2016
-$1.14 M
-$620.00 K(+92.5%)
-$942.00 K(+192.5%)
Sep 2016
-
-$322.00 K
-$322.00 K

FAQ

  • What is Krystal Biotech annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Krystal Biotech?
  • What is Krystal Biotech annual EBIT year-on-year change?
  • What is Krystal Biotech quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Krystal Biotech?
  • What is Krystal Biotech quarterly EBIT year-on-year change?
  • What is Krystal Biotech TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Krystal Biotech?
  • What is Krystal Biotech TTM EBIT year-on-year change?

What is Krystal Biotech annual earnings before interest & taxes?

The current annual EBIT of KRYS is $12.90 M

What is the all time high annual EBIT for Krystal Biotech?

Krystal Biotech all-time high annual earnings before interest & taxes is $12.90 M

What is Krystal Biotech annual EBIT year-on-year change?

Over the past year, KRYS annual earnings before interest & taxes has changed by +$152.87 M (+109.21%)

What is Krystal Biotech quarterly earnings before interest & taxes?

The current quarterly EBIT of KRYS is $34.93 M

What is the all time high quarterly EBIT for Krystal Biotech?

Krystal Biotech all-time high quarterly earnings before interest & taxes is $113.26 M

What is Krystal Biotech quarterly EBIT year-on-year change?

Over the past year, KRYS quarterly earnings before interest & taxes has changed by +$60.93 M (+234.39%)

What is Krystal Biotech TTM earnings before interest & taxes?

The current TTM EBIT of KRYS is $175.08 M

What is the all time high TTM EBIT for Krystal Biotech?

Krystal Biotech all-time high TTM earnings before interest & taxes is $175.08 M

What is Krystal Biotech TTM EBIT year-on-year change?

Over the past year, KRYS TTM earnings before interest & taxes has changed by +$329.99 M (+213.02%)